139 related articles for article (PubMed ID: 22553961)
1. Bortezomib and dexamethasone as first-line therapy for a patient with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome complicated by renal failure.
Li J; Zhang W; Kang WY; Cao XX; Duan MH; Zhou DB
Leuk Lymphoma; 2012 Dec; 53(12):2527-9. PubMed ID: 22553961
[No Abstract] [Full Text] [Related]
2. [POEMS syndrome. An interdisciplinary clinical challenge].
Braun SA; Albrecht P; Methner A; Hanneken S
Hautarzt; 2011 Oct; 62(10):722-5. PubMed ID: 21915731
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation.
Ishii Y; Yamazaki E; Ishiyama Y; Yamamoto E; Hattori Y; Hagihara M; Tomita N; Ishigatsubo Y
Int J Hematol; 2013 Dec; 98(6):723-8. PubMed ID: 24166587
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with bortezomib and thalidomide for POEMS syndrome associated with multicentric mixed-type Castleman's disease.
Wang X; Ye S; Xiong C; Gao J; Xiao C; Xing X
Jpn J Clin Oncol; 2011 Oct; 41(10):1221-4. PubMed ID: 21890654
[TBL] [Abstract][Full Text] [Related]
5. Effective induction therapy with subcutaneous administration of bortezomib for newly diagnosed POEMS syndrome: a case report and a review of the literature.
Zeng K; Yang JR; Li J; Wei Q; Yang YM; Liu T; Niu T
Acta Haematol; 2013; 129(2):101-5. PubMed ID: 23171959
[TBL] [Abstract][Full Text] [Related]
6. POEMS syndrome: a challenging diagnosis of a rare disease.
Creamer A; Gaastra B; Odogwu S; Whitelaw B
Br J Hosp Med (Lond); 2014 Jul; 75(7):408-9. PubMed ID: 25040523
[No Abstract] [Full Text] [Related]
7. Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).
Sobas MA; Alonso Vence N; Diaz Arias J; Bendaña Lopez A; Fraga Rodriguez M; Bello Lopez JL
Ann Hematol; 2010 Feb; 89(2):217-9. PubMed ID: 19636554
[No Abstract] [Full Text] [Related]
8. Bortezomib: a new therapeutic option for POEMS syndrome.
Kaygusuz I; Tezcan H; Cetiner M; Kocakaya O; Uzay A; Bayik M
Eur J Haematol; 2010 Feb; 84(2):175-7. PubMed ID: 19732138
[TBL] [Abstract][Full Text] [Related]
9. Successful bortezomib-based treatment in POEMS syndrome.
Tang X; Shi X; Sun A; Qiu H; Gu B; Zhou H; Xue S; Liu Y; Ruan C; Wu D
Eur J Haematol; 2009 Dec; 83(6):609-10. PubMed ID: 19674063
[No Abstract] [Full Text] [Related]
10. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.
Kim HJ; Yoon SS; Lee DS; Sohn SK; Eom HS; Lee JL; Chung JS; Kim K; Suh C; Won JH; Kim JS; Park JS; Kang HJ; Seong CM; Kim CS; Lee SJ; Lee JH
Ann Hematol; 2012 Feb; 91(2):249-56. PubMed ID: 21789621
[TBL] [Abstract][Full Text] [Related]
11. Making light of an interstitial process.
Thahseen A; Williams R; Gosney JR; Menzies D
Am J Respir Crit Care Med; 2012 Nov; 186(9):926. PubMed ID: 23118084
[No Abstract] [Full Text] [Related]
12. Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome.
Gao XM; Yu YY; Zhao H; Cai H; Zhang L; Cao XX; Zhou DB; Li J
Ann Hematol; 2021 Nov; 100(11):2755-2761. PubMed ID: 34331562
[TBL] [Abstract][Full Text] [Related]
13. Renal Fanconi syndrome as a cause of chronic kidney disease in patients with monoclonal gammopathy of undetermined significance: partially reversed renal function by high-dose dexamethasone with bortezomib.
Nishida Y; Iwama K; Yamakura M; Takeuchi M; Matsue K
Leuk Lymphoma; 2012 Sep; 53(9):1804-6. PubMed ID: 22385229
[No Abstract] [Full Text] [Related]
14. Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.
Dimopoulos MA; Roussou M; Gavriatopoulou M; Zagouri F; Migkou M; Matsouka C; Barbarousi D; Christoulas D; Primenou E; Grapsa I; Terpos E; Kastritis E
Clin Lymphoma Myeloma; 2009 Aug; 9(4):302-6. PubMed ID: 19717380
[TBL] [Abstract][Full Text] [Related]
15. Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens.
Roussou M; Kastritis E; Migkou M; Psimenou E; Grapsa I; Matsouka C; Barmparousi D; Terpos E; Dimopoulos MA
Leuk Lymphoma; 2008 May; 49(5):890-5. PubMed ID: 18464107
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of bortezomib in the treatment of multiple myeloma patients with renal failure].
Cao ZG; Liu M; Zhou HW
Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):74-5. PubMed ID: 23597473
[No Abstract] [Full Text] [Related]
17. Successful treatment of POEMS syndrome complicated by severe congestive heart failure with thalidomide.
Inoue D; Kato A; Tabata S; Kitai T; Takiuchi Y; Kimura T; Shimoji S; Mori M; Nagai Y; Togami K; Matsushita A; Nagai K; Maruoka H; Imai Y; Beppu M; Kawamoto M; Takahashi T
Intern Med; 2010; 49(5):461-6. PubMed ID: 20190484
[TBL] [Abstract][Full Text] [Related]
18. Late onset of bortezomib-associated cutaneous reaction following herpes zoster.
Varettoni M; Vassallo C; Borroni G; Mangiacavalli S; Zappasodi P; Rosso R; Lazzarino M; Corso A
Ann Hematol; 2007 Apr; 86(4):301-2. PubMed ID: 17131123
[No Abstract] [Full Text] [Related]
19. From the observation DAC: romidepsin revisited.
Knop S
Blood; 2011 Dec; 118(24):6231-2. PubMed ID: 22161846
[No Abstract] [Full Text] [Related]
20. Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience.
Zheng W; Wei G; Ye X; He J; Li L; Wu W; Shi J; Zhang J; Huang W; Xie W; Luo Y; Xue X; Lin M; Huang H; Cai Z
Leuk Res; 2009 Dec; 33(12):1615-8. PubMed ID: 19773080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
